Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Compugen Ltd.

Market Cap 193M 167M 154M 144M 269M 18.34B 274M 1.81B 707M 8.93B 724M 709M 30.91B P/E Ratio 2026 *
-7.03x
P/E Ratio 2027 * -7.13x
Enterprise Value 193M 167M 154M 144M 269M 18.34B 274M 1.81B 707M 8.93B 724M 709M 30.91B EV / Sales 2026 *
20.5x
EV / Sales 2027 * 12x
Free-Float
97.92%
Yield 2026 *
-
Yield 2027 * -
1 week-2.86%
Current month-22.43%
1 month-27.92%
3 months-7.69%
6 months+33.33%
Current year+33.33%
1 week 1.95
Extreme 1.95
2.14
1 month 1.95
Extreme 1.95
3.05
Current year 1.51
Extreme 1.51
3.24
1 year 1.3
Extreme 1.295
3.24
3 years 0.53
Extreme 0.53
3.24
5 years 0.51
Extreme 0.51
9.2
10 years 0.51
Extreme 0.51
19.9
Manager TitleAgeSince
Chief Executive Officer - 2025-09-22
Director of Finance/CFO 42 2024-08-14
Chief Operating Officer 49 2023-12-31
Director TitleAgeSince
Chairman 59 2025-09-22
Director/Board Member 59 2018-06-10
Director/Board Member 70 2018-06-10
Date Insider Type Main position Quantity % Market Cap.
04-23Fiscal year

Chief Technology Officer

6,000 0.0063%
04-23Fiscal year

Chief Executive Officer

15,000 0.0159%
04-13Fiscal year

Chief Technology Officer

6,000 0.0063%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.86%+22.89%+47.83% 193M
-0.35%+0.97%-15.96%-12.73% 42.96B
+3.11%+3.11%+274.29%+507.94% 31.73B
+0.22%-1.08%+14.03%-14.37% 30.22B
+1.62%-2.08%-4.36%+24.05% 28.94B
+4.09%-1.98%+11.99%+17.37% 23.87B
-1.63%+2.88%+53.73%+114.36% 13.57B
-0.40%-1.29%+6.06%+7.59% 12.96B
+1.14%+3.62% - - 13.39B
-0.74%-1.62%+105.71%+76.01% 12.2B
Average +0.71%+0.29%+52.04%+85.34% 21B
Weighted average by Cap. +1.02%+0.69%+54.43%+95.77%

Financials

2026 *2027 *
Net sales 9.41M 8.13M 7.49M 7.01M 13.14M 895M 13.35M 88.47M 34.5M 436M 35.33M 34.58M 1.51B 16.05M 13.86M 12.77M 11.96M 22.41M 1.53B 22.75M 151M 58.8M 742M 60.23M 58.95M 2.57B
Net income -27.6M -23.83M -21.96M -20.56M -38.53M -2.62B -39.13M -259M -101M -1.28B -104M -101M -4.42B -28.01M -24.19M -22.29M -20.87M -39.11M -2.66B -39.72M -263M -103M -1.3B -105M -103M -4.49B
Net Debt - -
Logo Compugen Ltd.
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Employees
75
Date Price Change Volume
26-06-12 2.040 $ 0.00% 206,978
26-06-11 2.040 $ +4.08% 359,262
26-06-10 1.960 $ -2.97% 352,744
26-06-09 2.020 $ -0.98% 462,765
26-06-08 2.040 $ -2.86% 458,936
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.040USD
Average target price
4.600USD
Spread / Average Target
+125.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGEN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!